ArticleBMJ open2013

Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.

Thomas Idorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.